AZ announces Phase I DS-8201 results by Anna Smith | May 2, 2019 | News | 0 Approximately one in five breast and gastric cancers are HER2-positive. Read More
Daiichi to test cancer drug combo by Selina McKee | Sep 21, 2018 | News | 0 Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of MSD to evaluate a potential new combination therapy for breast or lung cancers. Read More